PACS vs DVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 20, 2026

PACS

59.3
AI Score
VS
DVA Wins

DVA

62.8
AI Score

Investment Advisor Scores

PACS

59score
Recommendation
HOLD

DVA

63score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PACS DVA Winner
Revenue 2.85B 6.97B DVA
Net Income 157.06M 462.93M DVA
Net Margin 5.5% 6.6% DVA
Operating Income 229.37M 1.06B DVA
ROE 14.1% -60.5% PACS
ROA 2.8% 2.6% PACS
Total Assets 5.66B 17.71B DVA
Cash 164.45M 668.96M DVA
Current Ratio 0.91 1.47 DVA

Relative Price Performance (Last 90 Days)

PACS 1M: -2.4% · 3M: +18.9% DVA 1M: -24.1% · 3M: -10.5%

Current Technical Phase

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $43.99

DVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 25

RSI (14): 25.1 · Price: $176.19

Fundamentals Snapshot

Metric PACS DVA
Market Cap
Forward P/E 16.3 10.4
Trailing P/E 25.9 15.0
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.2%
EPS 1.69 11.88
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DVA is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.